World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
70
Citations
17460
World Ranking
20102
National Ranking
10006

Overview

Hans L. Tillmann is affiliated with East Carolina University in the United States. Their research primarily focuses on the fields of Medicine and Pharmacology, Toxicology, and Pharmaceutics. Within these domains, their work specifically spans subfields including Pharmacology, Epidemiology, Hepatology, Pathology and Forensic Medicine, and Oncology.

Their research topics broadly cover areas related to liver health and pharmacogenetics. These include:

  • Drug-Induced Hepatotoxicity and Protection
  • Liver Disease Diagnosis and Treatment
  • Pharmacogenetics and Drug Metabolism
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Hepatitis Viruses Studies and Epidemiology
  • Tea Polyphenols and Effects

Hans L. Tillmann has contributed articles to several peer-reviewed journals. Frequent publication venues include:

  • Drug Safety
  • Alimentary Pharmacology & Therapeutics
  • Hepatology
  • Clinical Gastroenterology and Hepatology
  • Gastroenterology

Their recent papers include:

  • How to Obtain a Nasopharyngeal Swab Specimen, 2020, New England Journal of Medicine
  • HLA-B*35:01 and Green Tea-Induced Liver Injury, 2020, Hepatology
  • Value of liver biopsy in the diagnosis of drug-induced liver injury, 2022, Journal of Hepatology
  • Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury, 2021, Clinical Gastroenterology and Hepatology
  • Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice, 2024, Journal of Personalized Medicine

Frequent co-authors in their collaborative research activities include:

  • Don C. Rockey
  • Shiva Poola
  • Kerry Sewell
  • Robert J. Fontana
  • Michael Merz

Best Publications

  • Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

    Alexander J. Thompson;Andrew J. Muir;Andrew J. Muir;Mark S. Sulkowski;Dongliang Ge

  • Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

    Stefanie U. Wiemann;Ande Satyanarayana;Martina Tsahuridu;Hans L. Tillmann

  • Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post–liver transplantation patients

    Eugene R. Schiff;Ching-Lung Lai;Stefanos Hadziyannis;Peter Neuhaus

  • Infection with GB virus C and reduced mortality among HIV-infected patients.

    Hans L. Tillmann;Hans Heiken;Adriana Knapik-Botor;Stefan Heringlake

  • Caspase 8 small interfering RNA prevents acute liver failure in mice.

    Lars Zender;Sebastian Hütker;Christian Liedtke;Hans Ludger Tillmann

  • Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin

    Jeanette J. McCarthy;Josephine H. Li;Alexander Thompson;Sunil Suchindran

  • Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

    Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth

  • A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

    Hans L. Tillmann;Alex J. Thompson;Keyur Patel;Manfred Wiese

  • An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response

    Alessandra Mangia;Alexander J. Thompson;Rosanna Santoro;Valeria Piazzolla

  • Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury

    Timothy J. Davern;Naga Chalasani;Robert J. Fontana;Paul Hideyo Hayashi

  • Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.

    Susan K. Murphy;Hyuna Yang;Cynthia A. Moylan;Herbert Pang

  • Hepatitis B and C in HIV-infected patients: Prevalence and prognostic value

    Johann Ockenga;Hans Ludger Tillmann;Christian Trautwein;Matthias Stoll

  • Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.

    Michael Charlton;Alexander James Thompson;Bart Veldt;Kymberly Watt

  • Long-term outcome of hepatitis C virus infection after liver transplantation

    K. H. W. Böker;G. Dalley;M. J. Bahr;H. Maschek

  • Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

    H. L. Tillmann;J. Hadem;L. Leifeld;K. Zachou

  • Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease

    Cynthia A. Moylan;Herbert Pang;Andrew Dellinger;Ayako Suzuki

  • Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation – possible role of mutations in the YMDD motif prior totransplantation as a risk factor for reinfection

    Jens Rosenau;Matthias J. Bahr;Hans L. Tillmann;Christian Trautwein

  • Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation

    C.–Thomas Bock;Hans L. Tillmann;Joseph Torresi;Jürgen Klempnauer

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Hans L Tillmann;John G McHutchison

  • Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

    Satyanarayana Ande;Stefanie Wiemann;Martina Tsahuridu;Hans Tillmann

Frequent Co-Authors

Michael P. Manns
Michael P. Manns Hannover Medical School
John G. McHutchison
John G. McHutchison Duke University
Alexander J. Thompson
Alexander J. Thompson Ascension Health
Christian Trautwein
Christian Trautwein RWTH Aachen University
Andrew J. Muir
Andrew J. Muir Duke University
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School
David Goldstein
David Goldstein University of New South Wales
Kevin V. Shianna
Kevin V. Shianna Duke University
Nezam H. Afdhal
Nezam H. Afdhal Beth Israel Deaconess Medical Center
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare but want alternatives to the traditional path of studying Medicine in the USA, there are several flexible online options to consider. Many aspiring healthcare professionals are now exploring roles that require less time in school while still delivering high career satisfaction.

For those without a nursing background, direct entry nurse practitioner programs for non-nurses online offer a fast-track to advanced nursing positions. Alternatively, enrolling in online adn programs can help you quickly start a career as a registered nurse, often in just two years.

If your interest lies in the administrative side of healthcare, consider medical billing and coding schools online to secure an in-demand career in healthcare management, often with financial aid opportunities.

For students worried about entrance exams, some options don't require standardized testing. Explore nursing schools that don't require teas or hesi for a smoother application process.

These pathways provide greater flexibility, making a healthcare career more accessible for a wider range of students.

Best Scientists Citing Hans L. Tillmann

Trending Scientists

Recently Published Articles